Fetal porcine cells, neurocell-pd (DrugBank: -)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 6 | Parkinson disease | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00226460 (ClinicalTrials.gov) | August 1997 | 23/9/2005 | Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease. | Parkinson's Disease | Drug: Fetal porcine cells, Neurocell-PD | Genzyme, a Sanofi Company | Diacrin/Genzyme Corporation LLC | Completed | 40 Years | 70 Years | Both | Phase 2 | United States |